MeSH term
Frequency | Condition_Probility | Antigens, CD/analysis | 3 | 0.0 |
Antigens, CD45/analysis | 2 | 0.0 |
Comparative Study | 6 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Humans | 50 | 0.0 |
Research Support, Non-U.S. Gov't | 31 | 0.0 |
Animals | 18 | 0.0 |
*Antigens, CD | 19 | 2.0 |
Female | 19 | 0.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Male | 19 | 0.0 |
Phenotype | 2 | 0.0 |
Blotting, Western | 5 | 0.0 |
CHO Cells | 4 | 0.0 |
Erythrocytes/metabolism | 2 | 1.0 |
Hamsters | 4 | 0.0 |
Haptoglobins/*chemistry | 2 | 100.0 |
Hemoglobins/*chemistry | 2 | 22.0 |
Ligands | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Surface Plasmon Resonance | 2 | 1.0 |
Time Factors | 6 | 0.0 |
Transfection | 7 | 0.0 |
Cells, Cultured | 7 | 0.0 |
Antigens, CD/metabolism | 2 | 0.0 |
Immunoenzyme Techniques | 3 | 0.0 |
Swine/*immunology | 2 | 6.0 |
Apoptosis | 2 | 0.0 |
Macrophages/*metabolism | 4 | 1.0 |
Adolescent | 4 | 0.0 |
Adult | 13 | 0.0 |
Case-Control Studies | 4 | 0.0 |
Flow Cytometry/methods | 2 | 0.0 |
Immunohistochemistry/methods | 2 | 0.0 |
Macrophages/*immunology | 3 | 1.0 |
Middle Aged | 11 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Endocytosis | 3 | 0.0 |
Haptoglobins/*metabolism | 2 | 16.0 |
Hemoglobins/*metabolism | 3 | 7.0 |
Molecular Sequence Data | 4 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Glucocorticoids/pharmacology | 3 | 2.0 |
Solubility | 6 | 0.0 |
Aged | 11 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 11 | 0.0 |
Enzyme-Linked Immunosorbent Assay/*methods | 2 | 1.0 |
Antigens/analysis | 2 | 1.0 |
Flow Cytometry | 6 | 0.0 |
Immunohistochemistry | 5 | 0.0 |
Antigens, Differentiation, Myelomonocytic/analysis | 2 | 0.0 |
Receptors, Cell Surface/analysis | 2 | 2.0 |
Cell Line | 2 | 0.0 |
Cytokines/pharmacology | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Dendritic Cells/metabolism | 3 | 6.0 |
Dexamethasone/pharmacology | 5 | 1.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Interleukin-4/pharmacology | 2 | 0.0 |
Macrophages/metabolism | 5 | 1.0 |
Mice | 4 | 0.0 |
Monocytes/*metabolism | 2 | 0.0 |
Phagocytosis | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
*Receptors, Cell Surface | 6 | 1.0 |
*Up-Regulation | 2 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Lipopolysaccharides/pharmacology | 4 | 0.0 |
Monocytes/drug effects/*metabolism | 3 | 2.0 |
Antigens, Differentiation, Myelomonocytic/*metabolism | 6 | 10.0 |
*Membrane Proteins | 4 | 0.0 |
*Receptors, Lipoprotein | 5 | 3.0 |
Macrophages/immunology/*metabolism | 2 | 6.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Inflammation | 2 | 0.0 |
Haptoglobins/metabolism | 2 | 8.0 |
Antigens, CD/*metabolism | 2 | 0.0 |
Macaca mulatta | 2 | 0.0 |
Receptors, Cell Surface/*metabolism | 4 | 0.0 |
Age Factors | 2 | 0.0 |
Down-Regulation | 3 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Monocytes/metabolism | 2 | 0.0 |
Antigens, CD/*blood | 2 | 1.0 |
Antigens, Differentiation, Myelomonocytic/*blood | 3 | 16.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
Receptors, Cell Surface/*blood | 3 | 16.0 |
Rats | 2 | 0.0 |
Hemoglobins/metabolism | 2 | 1.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
